Authors retract study that raised questions about drug used to treat COVID-19
A major study that raised questions about hydroxychloroquine's use against COVID-19 has been retracted.
Authors retract study that raised questions about drug used to treat COVID-19
USATODAY.com
0 shares
1 views
You might like
Related news coverage
11 critical questions about the coronavirus that remain unanswered, 6 months after the first cases were reported
Business Insider
· Experts continue to study the coronavirus as the number of people it infects and kills rises each day.
· Scientists are..
-
NA Proactive news snapshot: OTC Markets Group, NetCents Technology, EuroLife Brands, Pacton Gold, Tectonic Metals, Group Eleven Resources UPDATE ...
Proactive Investors
-
NA Proactive news snapshot: BevCanna Enterprises, Cabral Gold, VR Resources, The Valens Company, Metalla Royalty & Streaming, Namaste Technologies UPDATE …
Proactive Investors
-
NA Proactive news snapshot: Namaste Technologies, Orgenesis, Biocept, Ideanomics UPDATE …
Proactive Investors
-
Biotech companies to dominate at Proactive One2One Virtual Investor Forum on June 23
Proactive Investors
Advertisement
More coverage
Meet the 26 healthcare startups that top VCs say are poised to take off amid the coronavirus pandemic
Business Insider
· Business Insider asked 13 top venture capital investors which startups they think will thrive despite the coronavirus pandemic,..
-
Authors retract study that raised concern about drug for COVID-19
CBS News
-
'Serious' questions raised about hydroxychloroquine study, medical journal says
CBC.ca
-
Lancet says concerned about validity of widely cited hydroxychloroquine study
Reuters India
-
Lancet says concerned about validity of widely-cited hydroxychloroquine study
Reuters